- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |||
|---|---|---|---|---|---|---|
Aktuell sind keine Nachrichten verfügbar, die den gewählten Kriterien entsprechen. | ||||||
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MPH HEALTH CARE | 3,730 | 0,00 % | MPH Health Care AG - Diversifikation im Trend-Sektor Medizin | Die MPH Health Care AG aus Berlin ist auf die Bereiche Pharma und Patientenversorgung spezialisiert. Der strategische Fokus der Unternehmensgruppe liegt auf den Therapiegebieten "chronische Erkrankungen"... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 2,060 | -4,63 % | EyePoint Pharmaceuticals (EYPT) Investor Presentation - Slideshow | ||
| AMARIN | 14,900 | +2,05 % | A Chat With John Thero, CEO Of Amarin | ||
| SELLAS LIFE SCIENCES | 0,115 | -1,71 % | Sellas Life Sciences files for $50M mixed shelf | ||
| ANI PHARMACEUTICALS | 67,00 | +1,52 % | ANI Pharma Reports Positive Results From Cortrophin Gel Cortisol Response Study | WASHINGTON (dpa-AFX) - ANI Pharmaceuticals Inc. (ANIP) announced the receipt of clinical data on Cortrophin Gel (80 units/mL) from a study that evaluated the blood-level cortisol response... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 79,86 | +0,83 % | Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals | ||
| TITAN PHARMACEUTICALS | 0,187 | +9,36 % | TITAN PHARMACEUTICALS INC - 8-K, Current Report | ||
| ELITE PHARMACEUTICALS | 0,048 | -1,04 % | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Receives FDA Approval for Codeine and Acetaminophen Combo | NORTHVALE, NJ / ACCESSWIRE / September 12, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 4,900 | -0,81 % | Catalyst Pharma: Are the Risks Worth the Potential Rewards? | ||
| SYNTHETIC BIOLOGICS | 0,349 | +1,57 % | Synthetic Biologics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| KAZIA THERAPEUTICS | 0,280 | -6,04 % | KAZIA THERAPEUTICS LTD - 20-F, Annual and transition report of foreign private issuers | ||
| ADAMAS PHARMACEUTICALS | 3,480 | -3,33 % | Adamas Pharmaceuticals, Inc.: Adamas to Present at Upcoming Cantor Fitzgerald Investor Conference | ||
| ALLERGY THERAPEUTICS | 0,131 | -3,68 % | Allergy Therapeutics: Annual Report and Accounts | ||
| NUVO PHARMACEUTICALS | 0,200 | +9,89 % | Nuvo Pharmaceuticals Inc: Nuvo Pharmaceuticals to release Q3 2019 results Oct. 31 | ||
| ACURA PHARMACEUTICALS | 0,208 | 0,00 % | Acura Pharmaceuticals reports Q1 results |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
